ZA202205596B - Radiolabelled (lys3)bn-ipsma for the dual recognition of the psma and grpr proteins in vivo - Google Patents

Radiolabelled (lys3)bn-ipsma for the dual recognition of the psma and grpr proteins in vivo

Info

Publication number
ZA202205596B
ZA202205596B ZA2022/05596A ZA202205596A ZA202205596B ZA 202205596 B ZA202205596 B ZA 202205596B ZA 2022/05596 A ZA2022/05596 A ZA 2022/05596A ZA 202205596 A ZA202205596 A ZA 202205596A ZA 202205596 B ZA202205596 B ZA 202205596B
Authority
ZA
South Africa
Prior art keywords
ipsma
grpr
lys3
psma
radiolabelled
Prior art date
Application number
ZA2022/05596A
Inventor
Ferro Flores Guillermina
Eli Ocampo García Blanca
Escudero Castellanos Alondra
Alejandra Luna Gutiérrez Myrna
Leticia Santos Cuevas Clara
Patricia Jimenez Mancilla Nallely
Patricia Azorin Vega Erika
Original Assignee
Instituto Nac De Investigaciones Nucleares
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instituto Nac De Investigaciones Nucleares filed Critical Instituto Nac De Investigaciones Nucleares
Publication of ZA202205596B publication Critical patent/ZA202205596B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA2022/05596A 2019-10-23 2022-05-20 Radiolabelled (lys3)bn-ipsma for the dual recognition of the psma and grpr proteins in vivo ZA202205596B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MX2019012648A MX2019012648A (en) 2019-10-23 2019-10-23 Radiolabeled (lys3) bn-ipsma for dual recognition of psma and grpr proteins in vivo.
PCT/MX2019/000108 WO2021080409A1 (en) 2019-10-23 2019-10-24 Radiolabelled (lys3)bn-ipsma for the dual recognition of the psma and grpr proteins in vivo

Publications (1)

Publication Number Publication Date
ZA202205596B true ZA202205596B (en) 2023-01-25

Family

ID=75620589

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2022/05596A ZA202205596B (en) 2019-10-23 2022-05-20 Radiolabelled (lys3)bn-ipsma for the dual recognition of the psma and grpr proteins in vivo

Country Status (3)

Country Link
MX (1) MX2019012648A (en)
WO (1) WO2021080409A1 (en)
ZA (1) ZA202205596B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10806806B2 (en) * 2016-06-23 2020-10-20 Cornell University Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies
KR20190090394A (en) * 2016-11-30 2019-08-01 메모리얼 슬로안 케터링 캔서 센터 Inhibitor-functionalized micro-nanoparticles and methods thereof

Also Published As

Publication number Publication date
WO2021080409A1 (en) 2021-04-29
MX2019012648A (en) 2021-04-26

Similar Documents

Publication Publication Date Title
GB2613715B (en) Binding proteins specific for RAS neoantigens and uses thereof
HUE064376T2 (en) Ultra-long acting insulin-fc fusion proteins and methods of use
PH12019501837A1 (en) Radiolabeled anti-lag3 antibodies for immuno-pet imaging
SG11202011000SA (en) Taste and flavor-modifier proteins
IL287690A (en) Anti-hvem antibodies and use thereof
SG11202110400QA (en) Fusion protein and use thereof
IL291034A (en) Methods for radiolabelling grpr antagonists and their kits
IL290551A (en) Antibodies against ilt2 and use thereof
EP4069274A4 (en) Peptide conjugates and methods of use
ZA202100092B (en) Modified cas9 protein and use thereof
EP4083055A4 (en) Sugar-modified protein
GB201818576D0 (en) Arginase 2 polypeptides
WO2016205828A3 (en) Role of citrullination in diagnosing diseases
ZA202303625B (en) Fusion protein for detecting neurosyphilis and kit thereof
SG11202104912SA (en) Fusion protein and use thereof
EP3831945A4 (en) Protein heterodimer and use thereof
IL286216A (en) Tsg-6 antibodies and uses therefor
EP3585798A4 (en) In vivo protein n-acylation
ZA202205596B (en) Radiolabelled (lys3)bn-ipsma for the dual recognition of the psma and grpr proteins in vivo
EP3964533A4 (en) Protein heterodimer and use thereof
SG11202111462VA (en) Asx-specific protein ligases and uses thereof
IL290407A (en) Combination therapy with entpd2 and cd73 antibodies
ZA202200451B (en) Novel antibodies specific for cthrc1 and use thereof
IL285938A (en) Human serum albumin in formulations
EP4085064A4 (en) Looped proteins comprising cell penetrating peptides